Key result
Two cases link PRKCD gene fusions in benign fibrous histiocytoma to aggressive recurrence and metastasis.
Why the study?
Fibrous histiocytoma is typically benign but can rarely exhibit aggressive behavior with recurrence and metastasis, necessitating recognition for accurate diagnosis and management.
Case Report (n=2)
Complex chromosomal abnormalities such as PRKCD gene fusions may indicate a risk of aggressive clinical behavior in typically benign fibrous histiocytomas.
PRKCD fusions may signal aggressive fibrous histiocytoma; hypothesis-generating and requires validation before guiding care.
Dermatofibroma/fibrous histiocytoma is a common tumor of the dermis, composed of myofibroblasts, dendrocytes, and macrophages with characteristic entrapment of dermal collagen fibers at the periphery of the tumor. Various subtypes of dermatofibroma, including cellular, aneurysmal, and atypical dermatofibroma, are associated with an increased risk of recurrence, especially with incomplete excision. Two cases of benign fibrous histiocytoma with recurrence and metastasis are described. Patient 1 had a cellular fibrous histiocytoma with KIRREL1::PRKCD fusion presenting as a superficial and deep soft tissue mass involving the scapula and lateral clavicle. Patient 1 subsequently developed metastasis to the chest wall and thigh. Patient 2 had a recurrent aneurysmal fibrous histiocytoma with LAMTOR1::PRKCD fusion presenting as a large shoulder mass with invasion of the clavicle and lymph node metastasis. Patient 2 developed rapid local recurrence and PET-avid pulmonary nodules, radiologically consistent with metastasis. Fibrous histiocytoma is typically a morphologically benign neoplasm that only rarely exhibits clinically aggressive behavior with multiple recurrences and metastases. Although uncommon, recognition of this entity is important so that pathologists and sarcoma oncologists can ensure accurate diagnosis, multidisciplinary management, and appropriate clinical surveillance. In addition, complex chromosomal abnormalities may serve as useful indicators of fibrous histiocytoma with the risk of aggressive clinical behavior.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) conducted a case report in Fibrous histiocytoma (n=2). PRKCD gene fusions was evaluated on Recurrence and metastasis. Two cases of benign fibrous histiocytoma harboring PRKCD gene fusions exhibited clinically aggressive behavior with recurrence and metastasis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: